Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2023-10-13

New treatment option for heavily pre-treated multiple myeloma patients

View source ↗

Summary

The EMA announces a new treatment option for heavily pre-treated multiple myeloma patients, expanding options for this difficult-to-treat group.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications